More Effective Drug Screening with Cultured 3D Cell Clusters
Watch this video to learn more about the drug and product screening process at Likarda, a contract research organization. Dr Lisa Stehno-Bittel, President & CEO of Likarda, discusses the problems of screening drugs for efficacy. Due to the nature of cultured cells, it is very difficult to predict which drugs you’re working with are finally going to work in the human body. By employing the BioTek Cytation 5, Likarda is able to offer the most sophisticated 3D results, efficiently testing drugs in a representative manner.
To learn more about the Likarda, visit their website.
Thanks to Dr Lisa Stehno-Bittel and Caitlin Cole at Likarda for relating their BioTek experience with us.